振东制药：第六届董事会第五次会议决议公告

Core Viewpoint - The company, Zhendong Pharmaceutical, announced the approval of a proposal to adjust the upper limit of the share repurchase price during the fifth meeting of its sixth board of directors [2] Group 1 - The board of directors convened to discuss and approve the share repurchase price adjustment [2]